The American College of Obstetricians and Gynecologists (ACOG) has launched “Ask Me,” a campaign to educate women about emergency contraception and to encourage them to get an advance prescription from their physician in case they ever need it.
Leaders from ACOG, who launched the campaign in May, say emergency contraception is an important component of family planning and better access to it may help reduce the number of unplanned pregnancies and abortions in the United States. According to ACOG, nearly half of all US pregnancies are unplanned and more than half of the women who have an unplanned pregnancy were using a form of contraception when they became pregnant.
Grahic Jump Location
A new campaign called “Ask Me” seeks to educate women about emergency contraception and encourage provision of advance prescriptions for the drugs.
“Accidents happen. No form of contraception offers women 100% protection,” said ACOG president Michael T. Mennuti, MD. The campaign encourages women to ask about emergency contraception, and their OB-GYNs to provide information and a prescription to either hold and fill in an emergency or to fill immediately to have the medication on hand. Such prescriptions should be valid for about a year after they are written, though this may vary from state to state, according to ACOG. Currently, Plan B (levonorgestrel), the only dedicated emergency contraceptive sold in the United States, is available by prescription for $25 on average, though pricing may vary among pharmacies, according to Duramed Pharmaceuticals, a subsidiary of Barr Pharmaceuticals Inc, the drug's manufacturer. The drug's shelf life is 48 months between manufacture and expiration. Twenty other brands of oral contraceptives can be used as emergency contraception at doses that are higher than those employed for regular use, according to ACOG's Emergency Contraception Practice Bulletin (Obstet Gynecol. 2005;109:1443-1452). The bulletin, which provides guidelines for physicians on emergency contraception, can be ordered by sending an e-mail request including a complete mailing address to resources@acog.org.
“We hope to make EC [emergency contraception] a forethought, not an afterthought,” Mennuti said. Iffath A. Hoskins, MD, a representative of ACOG's committee on Health Care for Underserved Women, emphasized that any woman could find herself in need of emergency contraception, not just teenagers or those who are promiscuous. For example, women who have been raped, those who have a young infant or are nearing menopause may want to use emergency contraception to prevent a pregnancy.
The campaign was developed to help eliminate the logistical and political barriers that currently make it difficult for women to access emergency contraception, according to ACOG. Emergency contraceptives contain high doses of the same hormones used in birth control pills and may prevent pregnancy if used up to 72 hours after unprotected sex; they are most effective if used within 24 hours.
However, it may be difficult for a woman who has had unprotected sex or has been raped to contact her physician and obtain a prescription in time. Even women who seek treatment in an emergency department after a rape may not have timely access to emergency contraception. An analysis of the National Hospital Ambulatory Medical Care Survey for 1994-1999 found only 21% of the eligible women who were seen for rape treatment received the drugs (Rovi S and Shimoni N. J Am Med Womens Assoc. 2002;57:204-207). Efforts to address this time crunch by making the drugs available over-the-counter have been stalled, in part, by political pressure from groups that argue that emergency contraception would increase promiscuity or that it is tantamount to abortion.
In December 2003, an FDA advisory panel voted 23-4 to recommend that the agency approve over-the-counter sales of Plan B, citing the drug's safety and potential public health benefits of making it more readily available. But the agency denied the application, citing inadequate evidence for safety in young teens. The FDA has yet to make a decision on a second application by the manufacturer to make the drug available to women aged 17 years or older.
Meanwhile, ACOG and a number of medical organizations, including the American Academy of Pediatrics and the American Medical Association, have announced their support of making Plan B available over-the-counter. These groups cite evidence of the drug's safety, evidence that it cannot terminate an established pregnancy, and the potential public health benefits of reducing unintended pregnancies. Additionally, evidence has emerged that emergency contraceptive use does not increase promiscuity (Raine TR et al. JAMA. 2005;293:54-62).
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Comments are moderated and will appear on the site at the discretion of the Journal of American Medical Association editors. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Customize your page view by dragging & repositioning the boxes below.
and access these and other features:
Register Now
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.